Piramal Critical Care
- Company typePrivate
- Founded2002
- HeadquartersBethlehem, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Piramal Critical Care firmographics
Firmographics- Name
- Piramal Critical Care
- Legal name
- Piramal Critical Care
- Website
- https://piramalcriticalcare.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Piramal Critical Care industry classification
Industry- Product category
- Inhalation Anesthesia Pharmaceuticals
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industry
- Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)
Keywords
Where Piramal Critical Care is headquartered
LocationHeadquarters
- HQ city
- Bethlehem
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
Piramal Critical Care business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Pharmaceutical Product Sales: Sale of anesthesia and critical care pharmaceutical products including inhalation anesthetics, injectable pain management drugs, intrathecal therapies, and hospital generics to healthcare facilities globally
- Specialty Chemicals: Production and sale of specialty chemicals including hexafluoroisopropyl methyl ether, hexafluoroacetone trihydrate, and other fluorinated compounds
- Recycled Anesthetic Gas Processing: Processing captured waste anesthetic gases into Sevoflurane USP for human use through the Blue-Zone collaboration
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Piramal Critical Care product offering
Product offeringCore offering
Piramal Critical Care manufactures and globally distributes inhalation anesthetics (Sevoflurane, Desflurane, Isoflurane), injectable anesthesia and pain management drugs, intrathecal therapies for spasticity and chronic pain, hospital generic injectables, and specialty chemicals. The company supplies these products to hospitals, surgical centers, and healthcare providers across more than 100 countries.
Product overview
Piramal Critical Care offers a comprehensive portfolio of critical care pharmaceutical products, operating as a business division of Piramal Pharma Limited. The portfolio includes three core inhaled anesthetics (Sevoflurane, Desflurane, Isoflurane) for surgical anesthesia, intrathecal therapies (Gablofen® for spasticity, MITIGO™ for chronic pain), injectable anesthesia and pain management products (including opioid analgesics like Sublimaze®, Rapifen®, Sufenta®, Dipidolor®, and Hypnomidate®), injectable anti-infectives (Linezolid, Doxycycline, Pantoprazole), specialty injectables (neuromuscular blockers, sedatives, zinc sulfate), a plasma volume expander (Haemaccel), orphan drugs for rare metabolic diseases (Yargesa™ for Gaucher and Niemann-Pick Type C), pediatric/neonatal products (Neoatricon®), and specialty chemicals. The company is the third-largest player in the global inhaled anesthesia market and operates manufacturing facilities in the United States (Bethlehem, Pennsylvania) and India (Digwal and Dahej).
Differentiator
Problem solved
Functional benefit
Products and services
- Sevoflurane Inhaled anesthetic used for induction and maintenance of general anesthesia during surgical procedures; for hospitals and surgical centers.
- Desflurane Inhaled anesthetic with rapid onset and recovery, used for maintenance of general anesthesia; for hospitals and surgical centers.
- Isoflurane Inhaled anesthetic used for induction and maintenance of general anesthesia in human and veterinary applications.
- Gablofen (Baclofen Injection) Intrathecal therapy for the management of severe spasticity, including spinal cord injuries and multiple sclerosis; for hospitals and neurology specialists.
- MITIGO (Morphine Sulfate Injection USP) Intrathecal therapy for the management of severe chronic pain; for hospitals and pain management specialists.
- Sublimaze (Fentanyl Citrate) Injectable opioid analgesic for anesthesia and pain management; for hospitals and surgical centers.
- Rapifen (Alfentanil Hydrochloride) Short-acting injectable opioid analgesic used during anesthesia procedures; for hospitals and surgical centers.
- Sufenta (Sufentanil Citrate) Injectable opioid analgesic for anesthesia induction and maintenance; for hospitals and surgical centers.
- Dipidolor (Piritramide) Injectable opioid analgesic for moderate to severe pain management; for hospitals and surgical centers.
- Hypnomidate (Etomidate) Injectable anesthetic agent for induction of general anesthesia; for hospitals and surgical centers.
- Haemaccel (Emagel) Plasma volume expander used for fluid replacement therapy; for hospitals and emergency care settings.
- Yargesa (Miglustat) Oral therapy for Type 1 Gaucher disease and Niemann-Pick Type C disease; for hospitals and rare disease treatment centers.
- Glycopyrrolate Injection Anticholinergic agent used for reducing secretions during anesthesia and as a preoperative medication; for hospitals and surgical centers.
- Linezolid Injection Injectable anti-infective for treatment of resistant bacterial infections; for hospitals.
- Rocuronium Bromide Injection Non-depolarizing neuromuscular blocking agent for skeletal muscle relaxation during surgery; for hospitals and surgical centers.
- Succinylcholine Chloride Injection, USP Depolarizing skeletal muscle relaxant for rapid sequence intubation and surgical procedures; for hospitals and emergency care.
- Dexmedetomidine Injection, USP Sedative agent for intensive care unit sedation and procedural sedation; for hospitals and ICUs.
- Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU) Ready-to-use sedative injection for sedation in intubated patients; for hospitals and ICUs.
- Zinc Sulfate Injection, USP First-to-market generic zinc sulfate injection for the US market; for hospitals.
- Doxycycline for Injection, USP Injectable anti-infective for treatment of bacterial infections; for hospitals.
- Pantoprazole Sodium for Injection, USP Injectable proton pump inhibitor for gastrointestinal conditions; for hospitals.
- Ropivacaine ReadyfusOR Post-operative pain management local anesthetic delivery system; for hospitals and surgical centers.
- Neoatricon Pediatric and neonatal injectable product for critical care; for hospitals and neonatal ICUs.
- Hexafluoroisopropyl methyl ether (HFMOP) Specialty chemical used in pharmaceutical manufacturing; for pharmaceutical manufacturers.
- Hexafluoroacetone trihydrate (HFA.3H2O) Specialty chemical intermediate for pharmaceutical applications; for pharmaceutical manufacturers.
- Hexafluoroisopropanol (HFIP) Specialty chemical used as a processing aid in pharmaceutical manufacturing; for pharmaceutical manufacturers.
- 5-chlorothiophene-2-carboxylic acid Specialty chemical intermediate for pharmaceutical synthesis; for pharmaceutical manufacturers.
- 2-acetyl-5-chloro-thiophene Specialty chemical intermediate for pharmaceutical synthesis; for pharmaceutical manufacturers.
- Aminopropyl kojyl phosphate Specialty chemical for pharmaceutical applications; for pharmaceutical manufacturers.
Quantifiable outcome
- Environmental impact reduction through waste anesthetic gas capture and recycling program
- +1 more outcomes
Companies that use Piramal Critical Care
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Piramal Critical Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Piramal Critical Care partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Blue-Zone Technologies Ltd.coreCollaboration to capture, collect, and recycle waste anesthetic gases across their entire lifecycle. Blue-Zone's Phoenix Deltasorb system will be deployed in hospitals in France and Germany (pending European regulatory approval), while Piramal processes captured gases into Sevoflurane USP for human use in Canada. The partnership aims to reduce environmental impact of volatile anesthetics while ensuring continued access to essential inhaled anesthetics for patient care.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Piramal Critical Care competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Piramal Critical Care social profiles
Digital presencePiramal Critical Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Piramal Critical Care leadership team
Management profileNumber of profiles
Profiles11 records
Piramal Critical Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Piramal Critical Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Piramal Critical Care
What does Piramal Critical Care do?
Piramal Critical Care manufactures and globally distributes inhalation anesthetics (Sevoflurane, Desflurane, Isoflurane), injectable anesthesia and pain management drugs, intrathecal therapies for spasticity and chronic pain, hospital generic injectables, and specialty chemicals. The company supplies these products to hospitals, surgical centers, and healthcare providers across more than 100 countries.
Is Piramal Critical Care a public or private company?
Piramal Critical Care is a private company. It is classified as corporate owned and is currently operating.
When was Piramal Critical Care founded?
Piramal Critical Care was founded in 2002. It employs 251 to 500 people.
Where is Piramal Critical Care based?
Piramal Critical Care is headquartered in Bethlehem, United States, in the North America region.
How does Piramal Critical Care make money?
Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are specialty Chemicals and recycled Anesthetic Gas Processing.
Does Piramal Critical Care have an API?
No public API is recorded for Piramal Critical Care.
What industry is Piramal Critical Care in?
Piramal Critical Care's product category is Inhalation Anesthesia Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers). Its NAICS code is 3391 and its SIC code is 5122.